Archive summary

The Schizophrenia Drug That Nobody Expected: How a Forgotten Enzyme Could Crack the Disease’s Most Stubborn Problem

Northwestern researchers have identified HDAC5, an overexpressed brain enzyme, as a biomarker and drug target for schizophrenia's untreatable cognitive symptoms. Their selective inhibitor restored cognition in animal models, offering the first credible therapeutic approach to the disease's most disa

Summary of reporting by webpronews March 21, 2026 1 min read Markdown